Merck Q2 2023 Earnings Agenda ...

Merck & Co., Inc. (NYSE:MRK) Q2 2023 Earnings Conference Call August 1, 2023 9:00 AM ET Company Participants Peter Dannenbaum - VP, IR Robert Davis - Chairman & CEO Caroline Litchfield - CFO Dean Li - President, Merck Research Labs Conference Call Participants Geoff Meacham - Bank of America Mohit Bansal - Wells Fargo Louise Chen - Cantor Fitzgerald Seamus Fernandez - Guggenheim Akash Tewari - Jefferies Group Christopher Schott - JPMorgan Daina Graybosch - Leerink Partners Timothy Anderson - Wolfe Research ...

Merck & Co., Inc. (NYSE:MRK) Goldman Sachs 44th Annual Global Healthcare Conference June 12, 2023 7:00 PM ET Company Participants Caroline Litchfield - Chief Financial Officer Conference Call Participants Frank Clyburn - Goldman Sachs Dean Li - Executive Vice President and President Frank Clyburn Okay, let’s get underway. Welcome everybody to the afternoon session here at the Goldman Sachs 44th Annual Healthcare Conference. We are, as always, super excited to have Merck join us, CFO, Caroline Litchfield, Pr ...

PRESENT ASCO Investor Event Forward-l ...

Merck & Co., Inc. (NYSE:MRK) Special Event (Oncology Investor Event at ASCO 2023) June 5, 2023 7:00 PM ET Company Participants Peter Dannenbaum - VP, IR Dean Li - President, Merck Research Laboratories Eliav Barr - SVP, Head of Global Clinical Development & Chief Medical Officer Gregory Lubiniecki - VP, Late-Stage Oncology Development Marjorie Green - SVP, Head of Late Oncology Development Chirfi Guindo - Chief Marketing Officer Scot Ebbinghaus - VP, Late Oncology Development Conference Call Participants Tr ...

Merck & Co., Inc. (NYSE:MRK) Bank of America Securities 2023 Healthcare Conference Transcript May 10, 2023 11:40 AM ET Company Participants Geoff Meacham - Analyst, Bank of America Securities Caroline Litchfield - CFO, Merck & Co., Inc. Conference Call Participants Geoff Meacham Okay. Welcome to the second day of the BofA Healthcare Conference. My name is Geoff Meacham. I’m the Senior Biopharma Analyst. We’re thrilled today to have Merck with us. And Caroline Litchfield, CFO is with me on stage. Welcome, Ca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File No. 1-6571 Merck & Co., Inc. (Exact name of registrant as specified in its charter) New Jersey 22-1918501 (State or other jurisdiction o ...

Merck & Co., Inc. (NYSE:MRK) Q1 2023 Earnings Conference Call April 27, 2023 9:00 AM ET Company Participants Peter Dannenbaum - Vice President, Investor Relations Robert Davis - Chairman and CEO Caroline Litchfield - Chief Financial Officer Dr. Dean Li - President, Merck Research Labs Conference Call Participants Seamus Fernandez - Guggenheim Luisa Hector - Berenberg Chris Shibutani - Goldman Sachs Hardik Parikh - JPMorgan Carter Gould - Barclays Timothy Anderson - Wolfe Research Andrew Baum - Citigroup Mar ...

As filed with the Securities and Exchange Commission on February 24, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 _________________________________ FORM 10-K (MARK ONE) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 1-6571 Merck & Co., Inc. 126 Ea ...

Merck & Co., Inc. (NYSE:MRK) Q4 2022 Earnings Conference Call February 2, 2023 8:00 AM ET Company Participants Peter Dannenbaum - Vice President, Investor Relations Rob Davis - Chairman and CEO Caroline Litchfield - Chief Financial Officer Dr. Dean Li - President, Merck Research Labs Conference Call Participants Carter Gould - Barclays Andrew Baum - Citi Evan Seigerman - BMO Louise Chen - Cantor Tim Anderson - Wolfe Research Geoff Meacham - Bank of America Mohit Bansal - Wells Fargo Chris Schott - JPMorgan ...